A detailed history of Avidity Partners Management LP transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 7,417,155 shares of CNTX stock, worth $8.16 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
7,417,155
Previous 7,419,355 0.03%
Holding current value
$8.16 Million
Previous $14.8 Million 2.03%
% of portfolio
0.89%
Previous 0.73%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.79 - $2.66 $3,938 - $5,852
-2,200 Reduced 0.03%
7,417,155 $14.5 Million
Q2 2024

Aug 14, 2024

BUY
$1.24 - $2.19 $9.2 Million - $16.2 Million
7,419,355 New
7,419,355 $14.8 Million

Others Institutions Holding CNTX

About Context Therapeutics Inc.


  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $17.6M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.